Alpa Laboratories Limited

Symbol: ALPA.BO

BSE

93.11

INR

Market price today

  • 10.9238

    P/E Ratio

  • -1.0165

    PEG Ratio

  • 1.96B

    MRK Cap

  • 0.00%

    DIV Yield

Alpa Laboratories Limited (ALPA-BO) Stock Price & Analysis

Shares Outstanding

21.04M

Gross Profit Margin

0.35%

Operating Profit Margin

0.14%

Net Profit Margin

0.16%

Return on Assets

0.00%

Return on Equity

0.13%

Return on Capital Employed

0.00%

Company general description and statistics

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO:Mr. Mahendra Singh Chawla
Full-time employees:318
City:Indore
Address:33/2 Pigdamber
IPO:2007-08-07
CIK:

Alpa Laboratories Limited manufactures and sells pharmaceutical finished dosage forms in India. The company offers ethical, generic, and over the counter products in various finished dosage forms, including injections, tablets, capsules, eye and ear drops, ointments, creams, and gels for human and veterinary use. It also provides drugs in various categories, such as anti-infectives comprising antibacterial, antibiotics, antifungals, antiprotozoals, and antivirals; analgesics; anti-inflammatory drugs; cough and cold drugs; cardiovascular drugs; anti-diabetics; nutritional supplements; psychotropic drugs; and skin care preparations, as well as ear and eye care preparations. It sells its products through distributors, retail chemists, retail pharmacy stores, and hospitals. The company also exports its products to South and Central America, Africa, and Asia, Russia, Ukraine, Kazakhstan, and internationally. Alpa Laboratories Limited was founded in 1967 and is based in Indore, India.

General Outlook

In simple terms, Alpa Laboratories Limited has 21.041 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.350% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.135%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.157%. This tells us they're good at keeping money after all costs.

Return on Investments

Alpa Laboratories Limited's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.129%.

Stock Prices

Alpa Laboratories Limited's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $90.8, while its low point bottomed out at $83.15. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Alpa Laboratories Limited's stock market.

Profitability Ratios

ALPA.BO profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 19.28% underscores its earnings before tax deductions. The effective tax rate stands at 52.14%, revealing its tax efficiency. The net income per EBT, 81.41%, and the EBT per EBIT, 142.81%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 13.50%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin19.28%
Effective Tax Rate52.14%
Net Income per EBT81.41%
EBT per EBIT142.81%
EBIT per Revenue13.50%

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 7.03, and free cash flow per share, 7.03, depict cash generation on a per-share basis. The cash per share value, 48.50, showcases liquidity position. Lastly, the operating cash flow sales ratio, 0.13, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share7.03
Free Cash Flow per Share7.03
Cash per Share48.50
Operating Cash Flow Sales Ratio0.13
Free Cash Flow to Operating Cash Flow Ratio1.00

Debt and Leverage Ratios

An interest coverage of -379.95 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Interest Coverage-379.95

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 43.92, provides a glimpse into top-line earnings distributed across each share. Net income per share, 5.98, reflects the portion of profit attributed to each share. The book value per share, 63.96, represents the net asset value distributed per share, while the tangible book value per share, 63.92, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share43.92
Net Income Per Share5.98
Book Value Per Share63.96
Tangible Book Value Per Share63.92
Shareholders Equity Per Share63.96
Interest Debt Per Share1.13
Capex Per Share-0.54

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -16.38%, indicates top-line expansion, while the gross profit growth, -10.20%, reveals profitability trends. EBIT growth, -15.27%, and operating income growth, -15.27%, offer insights into operational profitability progression. The net income growth, -10.71%, showcases bottom-line expansion, and the EPS growth, -10.75%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-16.38%
Gross Profit Growth-10.20%
EBIT Growth-15.27%
Operating Income Growth-15.27%
Net Income Growth-10.71%
EPS Growth-10.75%
EPS Diluted Growth-10.75%
Operating Cash Flow Growth-10.42%
Free Cash Flow Growth0.37%
10-Year Revenue Growth per Share64.38%
5-Year Revenue Growth per Share49.29%
3-Year Revenue Growth per Share8.88%
10-Year Operating CF Growth per Share247.39%
5-Year Operating CF Growth per Share170.11%
3-Year Operating CF Growth per Share-49.92%
10-Year Net Income Growth per Share387.51%
5-Year Net Income Growth per Share348.30%
3-Year Net Income Growth per Share578.90%
10-Year Shareholders Equity Growth per Share43.72%
5-Year Shareholders Equity Growth per Share37.96%
3-Year Shareholders Equity Growth per Share34.08%
Receivables Growth16.38%
Inventory Growth-18.25%
Asset Growth7.75%
Book Value per Share Growth10.56%
Debt Growth-60.60%
SGA Expenses Growth-17.00%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 1,966,160,524, captures the company's total value, considering both debt and equity. Income quality, 0.57, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 0.05%, indicates the value of non-physical assets, and capex to operating cash flow, -12.65%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value1,966,160,524
Income Quality0.57
Sales General and Administrative to Revenue0.01
Intangibles to Total Assets0.05%
Capex to Operating Cash Flow-12.65%
Capex to Revenue-1.22%
Capex to Depreciation-84.71%
Graham Number92.77
Return on Tangible Assets7.53%
Graham Net Net43.76
Working Capital1,172,086,000
Tangible Asset Value1,344,941,000
Net Current Asset Value1,164,314,000
Average Receivables466,090,000
Average Payables149,906,500
Average Inventory140,524,000
Days Sales Outstanding198
Days Payables Outstanding89
Days of Inventory On Hand75
ROIC3.90%
ROE0.09%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 1.37, and the price to book ratio, 1.37, reflect the market's valuation relative to the company's book value. The price to sales ratio, 1.71, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 13.24, and price to operating cash flows, 13.24, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio1.37
Price to Book Ratio1.37
Price to Sales Ratio1.71
Price Cash Flow Ratio13.24
Price Earnings to Growth Ratio-1.02
Enterprise Value Multiple4.42
Price Fair Value1.37
Price to Operating Cash Flow Ratio13.24
Price to Free Cash Flows Ratio13.24
Price to Tangible Book Ratio1.51
Enterprise Value to Sales2.13
Enterprise Value Over EBITDA13.45
EV to Operating Cash Flow22.08
Earnings Yield6.19%
Free Cash Flow Yield3.83%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Alpa Laboratories Limited (ALPA.BO) on the BSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 10.924 in 2024.

What is the ticker symbol of Alpa Laboratories Limited stock?

The ticker symbol of Alpa Laboratories Limited stock is ALPA.BO.

What is company IPO date?

IPO date of Alpa Laboratories Limited is 2007-08-07.

What is company current share price?

Current share price is 93.110 INR.

What is stock market cap today?

The market cap of stock today is 1959090266.000.

What is PEG ratio in 2024?

The current -1.017 is -1.017 in 2024.

What is the number of employees in 2024?

In 2024 the company has 318.